Characterization of the origin, properties, functions and fate of cells is a fundamental task for the understanding of physiological and pathological phenomena. Despite the bulk of knowledge concerning the diverse characteristics of mammalian cells, some of them, such as B-1 cells, are still poorly understood. Here we report the results obtained in our laboratory on these cells in the last 10 years. After showing that B-1 cells could be cultured and amplified in vitro, a series of experiments were performed with these cells. They showed that B1 cells reside mostly in the peritoneal and pleural cavities, migrate to distant inflammatory foci, coalesce to form giant cells and participate in granuloma formation, both in vitro and in vivo. They are also able to present antigens to immunologically responsive cells and are endowed with regulatory properties. Further, we have also shown that these cells facilitate different types of infection as well as tumor growth and spreading. These data are presently reviewed pointing to a pivotal role that these cells may play in innate and acquired immunity.
INTRODUCTION
B-1 cells, first characterized by Hayakawa et al. in 1985 , express the phenotype IgD low IgM hi CD23-CD19 + CD11b + whilst conventional B cells are identified by the phenotype IgD hi IgM low CD23 + CD19 + CD11b -CD5 -. Further, B1a cells differ from B-1b cells by the expression of CD5 molecules in the former.
In addition to the promiscuous expression of markers for lymphoid and myeloid cell lineages, added with the CD5 T cell marker, these cells have also a peculiar distribution in the body's economy of mice: they are predominantly found in pleural and peritoneal cavities, being few in the spleen and almost absent in lymph nodes (Forster et al. 1991 , Marcos et al. 1989 , Hayakawa et al. 1985 . Contrary to the bone marrow origin of conventional B cells, B-1 are long-lived and auto-renewing cells (Lalor et al. 1989) .
The origin of B-1 cells is still a matter of intense investigation and two current hypotheses try to elucidate this issue. One, addressed by Herzenberg and Kantor (1993) says that B-1 cells do not differentiate from bone marrow precursors, but from cells which rearrange their Ig genes during fetal and neonatal period of life. Based on this hypothesis, the authors proposed that different lineages of B lymphocytes, B-1 and conventional B lymphocytes, are descendents of distinct precursors, each being active in different phases of the immune system development. This proposal was supported by experiments of cell reconstitution in SCID mice. It was demonstrated that cells from the fetal liver can reconstitute B-1 and B-2 cells Kantor 1993, Hardy and Hayakawa 1995) , whereas cells from the paraortic splancnopleura of 9 days embryo reconstitute the B-1a population (Godin et al. 1993) . Finally, grafts of fetal omentum reconstitute the populations of B-1a and B-1b cells (Solvason et al. 1991) . Based on these data, the authors concluded that B-1 cells appear in ontogeny before the emergence of conventional B cells, thus supporting the two cell lineage origin of B cells.
Conversely, Haughton and collaborators (1993) proposed that all sub-types of B cells emerge from a common progenitor, and that commitment with a cell lineage is dependent on the influence of antigenic selection (Cong et al. 1991) . The authors reported that conventional B cells, cultured in the presence of antiIgM and IL-6, assume the B-1 phenotype. Based on these observations, the authors concluded that the commitment with B-1 phenotype occurs after IgM expression on the cell surface of not fully differentiated B cells. Sustaining this hypothesis, the authors showed that B cells stimulated with thymus-independent antigens, such as carbohydrate from bacteria, or by auto-antigens such as DNA, can differentiate into B-1 cells.
B-1 CELLS HAVE A PECULIAR MORPHOLOGY
Until recently, the morphology of B-1 cells was not fully characterized. Abrahão et al. (2003) , in our laboratory, identified B-1 cells using colloidal gold immunocytochemical assays and purified B-1 cells from supernatants of adherent peritoneal cell cultures by a magnetic bead technique (Fig. 1) . The findings led the authors to demonstrate that, in mice, either B-1a or B-1b cells have a unique morphology, distinct from that of B-2 cells. The main morphological characteristic of these cells resides in bridges of the nuclear membrane, suggesting a lobular organization of the nucleus.
B-1 CELLS PROLIFERATE IN VITRO
B-1 cells represent from 10 to 15% of the total free cell population in the peritoneal cavity of mice. This paucity in cell number has been a limiting factor for the development of experiments directed to the better understanding of these peculiar cell subsets. Solving these limitations, we have developed a model to culture B-1 cells in vitro which allows the production of larger amounts of them. Briefly, total mouse peritoneal cells are cultured for about 1 h on glass or plastic dishes. Non-adherent cells are washed out and culture medium plus 10% fetal calf serum added to the cultures which are maintained up to seven days without changing the medium. Under these conditions, B-1 cells proliferate. (Almeida et al. 2001 Popi et al. (2009b) clearly demonstrated that these cells phagocytose higher numbers of Coxiella burneti in vitro as compared with bone marrow derived macrophages. Paradoxically, they have also shown that B-1DMP secrete large amounts of NO but kills bacteria in a lesser extent when compared with macrophages.
This phenomenon might result from contamination of the cultures with monocyte-derived macrophages as criticized by colleagues. Experimental results, however, disprove this hypothesis considering that: a) monocyte derived macrophages originate from stem cells in bone marrow of adult vertebrates. In mice, they have two waves of division to become a terminal differentiated cell, the monocyte, which may, under different types of stimulus, become a macrophage (Almeida et al. 2001) . As far as we know, once differentiated into bone marrow-derived macrophages, they no longer have the ability to divide. Our previous report on "macrophage" division in vitro and in vivo (Mariano and Spector 1974) was a misinterpretation of results, which will be commented later; b) if mice or total peritoneal cells are irradiated before the cells are used to culture B-1 cells as described, they do not grow, although macrophages still spread on the plastic surface. In other words, B-1cells are radio-sensitive and macrophages are well known radioresistant ones (e Brito et al. 2007 ); c) B-1 cells do not proliferate in culture when cells from Xid mice, an animal deprived of B-1 cells, are used and, finally, d) when anti-mouse IgM polyclonal antibody is added to the cultures plus mouse fresh serum as a source of complement, proliferation of B-1 cells is blocked, remaining only macrophages spread on the plastic surface.
One criticism for the data and for the interpretation that B-1 cells differentiate into a mononuclear phagocyte is the one of it being an in vitro phenomenon that does not occur in vivo. Evidences from our laboratory argue against these arguments considering that: a) B-1 cells migrate from the peritoneal cavity to a site of non-specific inflammation where they become morphologically similar to monocyte derived macrophages (Almeida et al. 2001) ; other reports in the literature confirm these observations (Borrello and Phipps 1996) ; b) our interpretation that foreign body giant cells resulted from the fusion of macrophages in vivo (Mariano and Spector 1974) has proved to be a mistaken interpretation since Bogsan et al. (2005) , in our laboratory, have clearly demonstrated that B-1 cells are essential for giant cell formation.
These data not only demonstrate a relevant participation of B-1b cells in the kinetics of the inflammatory process, but imposes a revisit of the identification and function of mononuclear cells in inflammatory lesions. Also, the participation of B-1 cells on results obtained from experiments with "pure" cultures of adherent peritoneal cells must also be re-evaluated considering that these cells are high producers of IL-10 (Gieni et al. 1997 ). This issue only will be solved when specific markers for B-1 cells in tissues become available.
Taken together, these data strongly points to the existence of a B-1 cell derived from mononuclear phagocyte in adult mice distinct from monocyte-derived macrophages. If so, B-1 cells, as defined nowadays, should not be considered as a full differentiated cellu-lar element of the immune system but a precursor cell which, under different physiological and pathological conditions, is induced to differentiate into a mononuclear phagocyte with functions not fully understood as yet (Popi et al. 2008) .
The implications of these observations in the physiopathology and immunity of B-1 cells remains open for further investigations. The "promiscuous" expression of both myeloid and lymphoid characteristics in a single cell type and the factors which govern B-1 cell differentiation in B-1DMP will certainly open new avenues for the understanding of lymphoid and myeloid cells physiopathology.
B-1 CELLS MIGRATE FROM THE PERITONEAL CAVITY TO A NON-SPECIFIC INFLAMMATORY LESION
The demonstration that B-1DMP has a high phagocytic ability the demonstration [and] (Paciorkowski et al. 2000) and Schistosoma mansoni (Gaubert et al. 1999) . Our results allow to state that B-1 cells have a role in the establishment of pulmonary lesions due to BCG, which favors inflammation, as clearly shown by experiments made in irradiated animals. At the 24 th day, the B-1a subpopulation seems to provide the main contribution to the infection, but both B-1a and B-1b are equally important for the establishment of inflammation after 38 days. Such cooperation between B-1a and B-1b was recently demonstrated with infections produced by Streptococcus pneumoniae (Haas et al. 2005) in which B-1a cells produce antibodies that limit infection, while B-1b cells generate a response that is sufficient to avoid death.
B-1 CELLS INFLUENCE GROWTH AND SPREADING OF MURINE MELANOMA IN VIVO
Our laboratory has generated three different lineages of murine melanoma: on the one hand, by in vivo selection and by cloning B16 mouse melanoma cells; two sublines with different behavior (high and low metastatic cells) were produced, thus creating a quantitative model for measuring metastatic capacity (Staquicini et al. 2003) .
On the other, starting from a non-tumorigenic melanocyte cell line (melan-a) (Bennett et al. 1987) , Jasiulionis and her group, along epigenetic studies, by sequential stressing procedures of adhesion and deadhesion, were able to lead these melanocytes to malignant cell lines that, in the end, became tumorigenic and metastatic. Since the intermediary lines were also kept and available, it is now possible to investigate the development of phenotypic differences from a normal to a very malignant cell line (Oba-Shinjo et al. 2006) . With these models at hand, it was possible to investigate the participation of B-1 cells in the whole process, thus reaching interesting results. Absence of B-1 cells, as happens in Xid mice as well as in animals whose peritoneal and pleural cavities were previously irradiated, is sufficient to partially arrest B16 tumor growth and inhibit formation of metastatic pulmonary nodules. This phenomenon is not dependent on IL-10, a cytokine produced in large amounts by these cells, and can be completely reverted by the reconstitution of the B-1 population with syngeneic cells (Staquicini et al. 2008) . The minor participation of IL-10 in this process was confirmed by using knockout mice (Pérez et al. 2008) , in which all results were very similar to those seen in wild type animals. It is dependent, however, on cell-to-cell interaction and not on soluble factors, since no differences in behavior were observed after co-cultivation with unattached cells in transwell plates. When co-cultivated, both B-1 and melanoma cells form tightly attached clusters, most probably dependent on adhesion molecules present on the surface of both cells. Also, we have shown that B-1 cells act by increasing the metastatic capacity of melanoma cells by up-regulating their amount and phosphorylation levels of the constitutionally phosphorylated extracellular signal-regulated kinase (ERK) (Pérez et al. 2008) . The high malignancy of the resulting cells is probably due to differential expression of surface molecules yet to be disclosed.
The transformation of non-tumorigenic melanocyte cells into a very malignant subline by the adhesion/deadhesion procedure represents a patient and time-consuming method. Similar results, however, can be obtained by simply cocultivating melan-a in the presence of B-1 cells for 48 to 72 hs. These melanocytic cells, even after the riddance of B-1 cells, become tumorigenic and metastatic such as those coming from the sequential stress experiments. Using phage display methodology, we tried to uncover surface molecules that could have differential expression and be potentially responsible for such malignant behavior. As yet, since experiments are still ongoing, preliminary results have shown an abnormal expression of some proteoglycans, mainly Perlecan and Syndecan (A. Araujo et al., unpublished data), but further investigations are needed to assume that these are the only molecules that so drastically modify the metastatic phenotype of these cells. On the other hand, we have already provided enough evidence of B-1 cells influencing the out coming of murine melanoma.
FINAL COMMENTS
Little is known on the physiology of B-1 cells, as are their functions and insertion on the immune system as a whole. This is most probably due to their paucity and localization and to the difficulties of their cultivation until recently. Literature is scarce and the number of research groups dealing with these issues is very small. These circumstances made the contributions on this knowledge provided by our group already recognized by the community of investigators involved with B cells. We described how to cultivate and amplify the number of cells, showed their participation on different inflammatory processes, as well as their influence on the outcome of some tumor disorders. We also added information on migration, participation on granuloma formation and interactions with other cells, either of the immune system or from different origins. The not fully differentiated condition of these cells, which allow them, under some special situations, to perform myeloid functions, as yet confined to macrophages, must not be neglected.
Thus, our knowledge on the participation of B-1 cells in physiology and pathology has become primordial. Nevertheless, evidence that these cells are endowed with tolerogenic properties, among others, is an exciting clue to explain unsolved problems in immunopathology. One might speculate that the absence of B-1 cells in Xid mice renders these animals more resistant to infection and tumor growth due to the release of T cell specific functions by unknown regulatory mechanisms imposed by B-1 cells. Once definitely proved, these cells might become a population to be regarded as one of the most important lineages composing the immune system. 
